Original news and analysis on international IP policy
Gavin Cloherty is associate director of scientific affairs at the US molecular diagnosis developer Abbott Molecular. Abbott has a long-standing history of developing tests for detecting and monitoring hepatitis, among other areas. With Intellectual Property Watch, Cloherty discussed the burden of hepatitis C, the process of diagnosis and the importance of diagnosis for curbing and treating the disease.
The World Health Organization today (24 May) adopted a one-year plan to come up with a policy on engagement with “non-state actors” – industry, nongovernmental groups, foundations and academics.
A new draft decision putting action on a proposal for external actors' engagement with the World Health Organization on track for next year will be considered by a committee at the World Health Assembly.
Country officials, academics and leading global health advocates this week raised one of the key concerns of this year’s World Health Assembly: innovation and access to medicines in middle-income countries. Government procurement strategies, voluntary and compulsory licensing, de-linkage models and UNITAID mechanisms were among some of the solutions put forward.
After several drafting sessions this week meant to finalise a framework to govern the engagement of the World Health Organization with the private sector, nongovernmental organisations, foundations and academics, country delegates admitted defeat today at the World Health Assembly.
Multiple stakeholders are pushing for a World Health Organization-led global action plan to curb antimicrobial resistance.
A proposal to increase the engagement of “non-state actors” - industry, nongovernmental organisations, foundations and academics - in the activities of the World Health Organization is under intense debate at the annual World Health Assembly this week.
A side event to this week’s World Health Assembly highlighted progress being made in a public-private partnership on the elimination of sleeping sickness, a disease that occurs in some developing countries.
The Geneva IP delegates list is updated! As a special feature for our subscribers, Intellectual Property Watch has assembled a new list of many of the leading government delegates working on intellectual property issues in Geneva.
BASEL -- Students from around the world are gathering momentum to challenge their universities’ licensing policies and research and development systems. That was one of the messages emerging from the annual meeting of Universities Allied for Essential Medicines (UAEM) Europe.